ZA99740B - Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction. - Google Patents

Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction.

Info

Publication number
ZA99740B
ZA99740B ZA9900740A ZA99740A ZA99740B ZA 99740 B ZA99740 B ZA 99740B ZA 9900740 A ZA9900740 A ZA 9900740A ZA 99740 A ZA99740 A ZA 99740A ZA 99740 B ZA99740 B ZA 99740B
Authority
ZA
South Africa
Prior art keywords
prevention
treatment
trifluoromethoxybenzothiazole
amino
application
Prior art date
Application number
ZA9900740A
Other languages
English (en)
Inventor
Andrees Bohme
Thierry Canton
Alain Boireau
Assunta Imperato
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA99740B publication Critical patent/ZA99740B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA9900740A 1998-02-06 1999-01-29 Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction. ZA99740B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9801402A FR2774592B1 (fr) 1998-02-06 1998-02-06 Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet

Publications (1)

Publication Number Publication Date
ZA99740B true ZA99740B (en) 1999-08-02

Family

ID=9522673

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900740A ZA99740B (en) 1998-02-06 1999-01-29 Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction.

Country Status (18)

Country Link
US (1) US6245791B1 (de)
EP (1) EP1052989B1 (de)
JP (1) JP5127092B2 (de)
KR (1) KR100574378B1 (de)
AT (1) ATE245982T1 (de)
AU (1) AU761978B2 (de)
CA (1) CA2319686C (de)
DE (1) DE69909970T2 (de)
DK (1) DK1052989T3 (de)
EA (1) EA002676B1 (de)
ES (1) ES2199541T3 (de)
FR (1) FR2774592B1 (de)
IL (2) IL137608A0 (de)
NO (1) NO327819B1 (de)
NZ (1) NZ506124A (de)
PT (1) PT1052989E (de)
WO (1) WO1999039710A1 (de)
ZA (1) ZA99740B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60041365D1 (de) * 1999-06-04 2009-02-26 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Verwendung von Riluzol zur Behandlung Multipler Sklerose
EP3265448B1 (de) * 2015-03-03 2021-12-29 Biohaven Pharmaceutical Holding Company Ltd. Riluzolprodrugs und deren verwendung
FI3706739T3 (fi) * 2017-11-12 2024-12-27 Biohaven Therapeutics Ltd Rilutsoliaihiolääkkeiden käyttö ataksioiden hoitamiseksi
CN112203692A (zh) * 2018-05-27 2021-01-08 拜尔哈文制药股份有限公司 利鲁唑口腔崩解片用于治疗疾病的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68901859T2 (de) * 1988-12-15 1993-01-14 Rhone Poulenc Sante 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.
FR2726271B1 (fr) * 1994-10-26 1996-12-06 Rhone Poulenc Rorer Sa Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole

Also Published As

Publication number Publication date
CA2319686C (fr) 2009-06-23
ES2199541T3 (es) 2004-02-16
FR2774592B1 (fr) 2000-03-17
US6245791B1 (en) 2001-06-12
AU761978B2 (en) 2003-06-12
KR20010040671A (ko) 2001-05-15
AU2171199A (en) 1999-08-23
ATE245982T1 (de) 2003-08-15
EA002676B1 (ru) 2002-08-29
EP1052989B1 (de) 2003-07-30
NZ506124A (en) 2003-07-25
JP2002502819A (ja) 2002-01-29
IL137608A (en) 2006-09-05
NO20003785L (no) 2000-07-24
DE69909970T2 (de) 2004-05-27
EA200000816A1 (ru) 2001-02-26
EP1052989A1 (de) 2000-11-22
DK1052989T3 (da) 2003-11-17
IL137608A0 (en) 2001-07-24
CA2319686A1 (fr) 1999-08-12
NO20003785D0 (no) 2000-07-24
DE69909970D1 (de) 2003-09-04
PT1052989E (pt) 2003-12-31
WO1999039710A1 (fr) 1999-08-12
JP5127092B2 (ja) 2013-01-23
FR2774592A1 (fr) 1999-08-13
NO327819B1 (no) 2009-09-28
KR100574378B1 (ko) 2006-04-26

Similar Documents

Publication Publication Date Title
ZA200006042B (en) Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections.
PT1071422E (pt) Associações de riluzole e levodopa para o tratamento da doença de parkinson
CA2154572A1 (fr) Application du riluzole dans le traitement du neuro-sida
DE60205899D1 (en) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
GC0000155A (en) 6-Hydroxy-indazole derivatives for treating glaucoma.
AU2002222180A1 (en) The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired pasticity
BG105197A (en) Polymorph form of a medicament
AP2002002387A0 (en) Method of inhibiting amyloid aggregation and imaging amyloid deposits.
AU5038299A (en) Process for the biocidal treatment of surfaces
WO1998027930A3 (en) New use of aminopiperazine derivatives
GB9907571D0 (en) Compounds
AU1160700A (en) Ppar gamma ligands
ZA99740B (en) Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction.
WO2001041709A3 (en) Methods for treating cell death diseases and inflammation
MXPA03004017A (es) Metodo para el tratamiento de inflamacion.
ZA953975B (en) Glucopyranoside benzothiophenes
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
MXPA03001472A (es) Compuestos para el tratamiento de trastornos adictivos.
TW200420561A (en) Antimicrobial 1-aryl dihydropyridone compounds
AU1230800A (en) Controlled delivery of antidepressants
PL352119A1 (en) Derivatives of aminotetraline for treatment of cardiovascular diseases
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
IL127930A0 (en) Verapamil as a medicament for the treatment of angina
ZA200006374B (en) Compound for the treatment of female sexual dysfunction.
AU4385499A (en) Pharmaceutical composition for treating sexual dysfunction